Abstract
We describe a unique new collaboration which allows linkage of administrative databases in Southern Israel, and hence ascertain risk/safety of prescription drugs in pregnancy. The advantages of this system include availibilty of rigorous data confounders, solid data on maternal conditions for which the drug is given, ability to capture all cases of elective abortions and not just live births, and ability to construct drug doses.
Keywords: Pregnancy, malformations, medication, fetus, neonate, BeMORE, Drugs, central nervous system, corticosteroids, Clalit Health Services, Demog-ICD9 database, CDC, ORs, CIs, congenital malformations, neural tube, cardiovascular defects, abortion
Current Drug Safety
Title: BeMORE: A Novel Method for Detection of Adverse Fetal Effects Induced by Drugs
Volume: 6 Issue: 1
Author(s): Ilan Matok, Amalia Levy, Rafael Gorodischer, Eitan Lunenfeld, Yehuda Limony and Gideon Koren
Affiliation:
Keywords: Pregnancy, malformations, medication, fetus, neonate, BeMORE, Drugs, central nervous system, corticosteroids, Clalit Health Services, Demog-ICD9 database, CDC, ORs, CIs, congenital malformations, neural tube, cardiovascular defects, abortion
Abstract: We describe a unique new collaboration which allows linkage of administrative databases in Southern Israel, and hence ascertain risk/safety of prescription drugs in pregnancy. The advantages of this system include availibilty of rigorous data confounders, solid data on maternal conditions for which the drug is given, ability to capture all cases of elective abortions and not just live births, and ability to construct drug doses.
Export Options
About this article
Cite this article as:
Matok Ilan, Levy Amalia, Gorodischer Rafael, Lunenfeld Eitan, Limony Yehuda and Koren Gideon, BeMORE: A Novel Method for Detection of Adverse Fetal Effects Induced by Drugs, Current Drug Safety 2011; 6 (1) . https://dx.doi.org/10.2174/157488611794480052
DOI https://dx.doi.org/10.2174/157488611794480052 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Player on An Old Field; the Keap1/Nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome
Current Diabetes Reviews Management of Primary Aldosteronism: Its Complications and Their Outcomes After Treatment
Current Vascular Pharmacology Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
Current Vascular Pharmacology Enzymes as Target Antigens of Liver-Specific Autoimmunity: The Case of Cytochromes P450s
Current Medicinal Chemistry Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease
Current Medicinal Chemistry Further Vitamin D Analogs
Current Vascular Pharmacology The Effects of Genetic Polymorphism on Treatment Response of Recombinant Human Growth Hormone
Current Drug Metabolism Vaginal Birth After Cesarean: How to Counsel Patients Using the Evidence
Current Women`s Health Reviews Pioglitazone and Rosiglitazone: Effects of Treatment with a Thiazolidinedione on Lipids and Non Conventional Cardiovascular Risk Factors
Current Clinical Pharmacology “Something is Wrong in the Ras Kingdom” - Evidence for the Involvement of p21Ras/MAP Kinase in Autoimmune Diseases
Current Rheumatology Reviews Advances in Treating the Ischaemic Diabetic Foot
Current Vascular Pharmacology A Primary Reduced TCA Flux Governs Substrate Oxidation in T2D Skeletal Muscle
Current Diabetes Reviews Effects of Renin-Angiotensin-Aldosterone System Blockade on Diabetic Patients
Current Enzyme Inhibition Evolving Strategies in Manipulating VEGF/VEGFR Signaling for the Promotion of Angiogenesis in Ischemic Muscle
Current Pharmaceutical Design Painful Peripheral Neuropathies
Current Neuropharmacology Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Endocrine, Metabolic & Immune Disorders - Drug Targets What Restricts the Clinical Use of Nicotinic Acid?
Current Vascular Pharmacology The role of NADPH Oxidase in Vascular Disease – Hypertension, Atherosclerosis & Stroke
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Women`s Health Reviews Metal Catalyzed Oxidation of Alpha-Synuclein – A Role for Oligomerization in Pathology?
Current Alzheimer Research